115 related articles for article (PubMed ID: 6151604)
21. Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease.
Bell H; Schrumpf E; Fagerhol MK
Scand J Gastroenterol; 1990 Aug; 25(8):788-92. PubMed ID: 2402584
[TBL] [Abstract][Full Text] [Related]
22. Serum isoamylases in acute and chronic liver disease.
Skrha J; Stĕpán J; Hazuka V; Pacovský V
Z Gastroenterol; 1984 May; 22(5):255-8. PubMed ID: 6741202
[TBL] [Abstract][Full Text] [Related]
23. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients.
Mathiesen UL; Franzén LE; Frydén A; Foberg U; Bodemar G
Scand J Gastroenterol; 1999 Jan; 34(1):85-91. PubMed ID: 10048738
[TBL] [Abstract][Full Text] [Related]
24. [Chronic active hepatitis and cirrhosis in a 60-year-old man with alpha-1-antitrypsin deficiency].
Dramard JM; Allouche M; Marche C; Gislon J
Gastroenterol Clin Biol; 1983 Jan; 7(1):81-5. PubMed ID: 6601599
[No Abstract] [Full Text] [Related]
25. [Preliminary results of the studies of serum monoamine oxidase and ceruloplasmin activities in patients with chronic hepatitis and liver cirrhosis].
Krasnowska M; Cieślińska A; Jankowska R; Czapska J
Wiad Lek; 1985 Oct; 38(20):1420-4. PubMed ID: 4095992
[No Abstract] [Full Text] [Related]
26. The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.
Tadmor T; Bejar J; Attias D; Mischenko E; Sabo E; Neufeld G; Vadasz Z
Am J Hematol; 2013 May; 88(5):355-8. PubMed ID: 23494965
[TBL] [Abstract][Full Text] [Related]
27. Aldehyde dehydrogenase (E.C. 1.2.1.3) in chronic alcoholic liver diseases.
Nilius R; Zipprich B; Krabbe S
Hepatogastroenterology; 1983 Aug; 30(4):134-6. PubMed ID: 6629303
[TBL] [Abstract][Full Text] [Related]
28. Hepatic gamma-glutamyl transferase and hepatic fibrosis in patients with alcoholic liver disease.
Yamauchi M; Kimura K; Kawase H; Watanabe Y; Kitahara T; Ogura K; Fujisawa K; Kameda H
Enzyme; 1984; 32(2):110-5. PubMed ID: 6149933
[TBL] [Abstract][Full Text] [Related]
29. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis.
Kagan HM
Pathol Res Pract; 1994 Oct; 190(9-10):910-9. PubMed ID: 7899140
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat.
Siegel RC; Chen KH; Greenspan JS; Aguiar JM
Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2945-9. PubMed ID: 26918
[TBL] [Abstract][Full Text] [Related]
31. [Activities of glutathione enzymes in liver biopsy specimens in chronic lesions of hepatocytes].
Matiushin BN; Loginov AS; Tkachev VD
Klin Lab Diagn; 1998 Apr; (4):16-8. PubMed ID: 9621574
[TBL] [Abstract][Full Text] [Related]
32. [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].
Takahashi A; Sekiya C; Yazaki Y; Ono M; Sato H; Hasebe C; Ishikawa Y; Okuno K; Yamada M; Namiki M
Hokkaido Igaku Zasshi; 1986 May; 61(3):431-6. PubMed ID: 3744290
[TBL] [Abstract][Full Text] [Related]
33. Xanthine oxidoreductase is present in bile ducts of normal and cirrhotic liver.
Martin HM; Moore KP; Bosmans E; Davies S; Burroughs AK; Dhillon AP; Tosh D; Harrison R
Free Radic Biol Med; 2004 Oct; 37(8):1214-23. PubMed ID: 15451061
[TBL] [Abstract][Full Text] [Related]
34. Paraoxonase activity in sera of patients with non-alcoholic fatty liver disease.
Fedelesova M; Kupcova V; Luha J; Turecky L
Bratisl Lek Listy; 2017; 118(12):719-720. PubMed ID: 29322801
[TBL] [Abstract][Full Text] [Related]
35. Liver gamma-glutamyltransferase activity in viral liver disease.
Itoh S; Nakajima M
Digestion; 1986; 33(3):121-5. PubMed ID: 2868954
[TBL] [Abstract][Full Text] [Related]
36. Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics.
Ventura P; Rosa MC; Abbati G; Marchini S; Grandone E; Vergura P; Tremosini S; Zeneroli ML
Liver Int; 2005 Feb; 25(1):49-56. PubMed ID: 15698398
[TBL] [Abstract][Full Text] [Related]
37. Immunological characterization of bovine lysyl oxidase.
Burbelo PD; Kagan HM; Chichester CO
Comp Biochem Physiol B; 1985; 81(4):845-9. PubMed ID: 2864220
[TBL] [Abstract][Full Text] [Related]
38. [Regulation of mRNA expression of human UDP-glucuronosyltransferase in hepatitis and liver cirrhosis patients].
Zhang Y; Li YQ; Zhang SZ; Chu CL; Li WJ; Yang XY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):64-5. PubMed ID: 15670504
[No Abstract] [Full Text] [Related]
39. Monoclonal antibodies to human lysyl oxidase.
Burbelo PD; Monckeberg A; Chichester CO
Coll Relat Res; 1986 Jun; 6(2):153-62. PubMed ID: 2873920
[TBL] [Abstract][Full Text] [Related]
40. Arginase and xanthine oxidase activity in liver tissue in pathological conditions.
Bhide SV; Shah S; Desai MP
Biochem Med; 1974 Apr; 9(4):386-9. PubMed ID: 4832207
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
